| Entry |
|
|---|
| Name |
Phenglutarimide (INN) |
|---|
| Formula |
C17H24N2O2
|
|---|
| Exact mass |
288.1838
|
|---|
| Mol weight |
288.3847
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiparkinsonian, Muscarinic acetylcholine receptor antagonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04A ANTICHOLINERGIC AGENTS
N04AA Tertiary amines
N04AA09 Phenglutarimide
D07301 Phenglutarimide (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
D07301 Phenglutarimide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D07301 Phenglutarimide (INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 21
1 C5x C 23.4487 -16.0284
2 C1x C 23.4487 -17.4282
3 C1x C 24.6610 -18.1282
4 C1z C 25.8734 -17.4282
5 C5x C 25.8734 -16.0284
6 N1x N 24.6610 -15.3284
7 O5x O 22.2364 -15.3284
8 O5x O 27.1044 -15.3174
9 C1b C 27.2733 -17.4282
10 C8y C 26.2372 -18.7865
11 C1b C 27.9792 -18.6514
12 N1c N 29.3978 -18.6520
13 C1b C 30.1133 -17.4147
14 C1b C 30.0827 -19.8392
15 C1a C 31.4979 -17.4158
16 C1a C 31.4976 -19.8400
17 C8x C 25.5907 -19.9950
18 C8x C 26.3223 -21.1886
19 C8x C 27.7218 -21.2218
20 C8x C 28.3764 -19.9458
21 C8x C 27.6448 -18.7522
BOND 22
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 1 7 2
8 5 8 2
9 4 9 1
10 4 10 1
11 9 11 1
12 11 12 1
13 12 13 1
14 12 14 1
15 13 15 1
16 14 16 1
17 10 17 2
18 17 18 1
19 18 19 2
20 19 20 1
21 20 21 2
22 10 21 1
|
|---|
